灵麦医药聚焦
“三亲”体外受精试管婴儿治疗不孕不育症
全球及中国不孕不育症的发病率和治疗进展
不孕不育症的主要病因
全球及中国不孕不育症治疗指南的比较
全球及中国不孕不育症的研发管线
全球及中国不孕不育症治疗领先企业
“Three-Parent” IVF Trialed for Infertility
Incidence and treatment progress of Infertility worldwide and in China
The key causes of Infertility
Comparison of global and China treatment guidelines for Infertility
Global and China pipeline of infertility research projects
Leading players globally and in China
活动详情
日期: 2019年10月18日周五 4:00 PM - 5:00PM
地点: Webex
演讲: 曹玲玲,CEO & 灵麦医药创始人; 王海盛,医学顾问
报名：021-5386 3003
RSVP：本次讲座免费(优先灵麦医药现有VIP客户) 请于2019年10月17日前注册
DATE: Friday October 18, 2019 4:00 PM - 5:00 PM
VENUE: Webex
PRESENTERS：Lingling Cao, CEO & Founder ，Dr. Hank Wang, Medical advisor
REGISTER ：+86 21 5386 3003
RSVP：This is a FREE event VIP tickets priority for Lingmed current clients. Please RSVP by October 17, 2019
活动日程
16 : 00-16 : 10 灵佰服务及项目简介 -曹玲玲 主讲
16 : 10-16 : 45 不孕不育？“三亲”体外受精试管婴儿技术开启IVF新纪元！不孕不育症专题市场潜力探讨。-王海盛博士 主讲
16 : 45-16 : 55 提问和讨论
16 : 55-17 : 00 总结及反馈
16 : 00-16 : 10 Linkedbio services & projects introductions - by LingLing Cao
16 : 10-16 : 45 Infertility? From the “Three-Parent” IVF Trialed for Infertility to current market trend discussion. - by Dr. Hank Wan
16 : 45-16 : 55 Panel discussions
16 : 55-17 : 00 Q&A
出席嘉宾
曹玲玲 CEO & 创始人
曹女士毕业于上海第二医科大学现交通大学医学院的临床医学系。并在欧洲荷兰马斯特里斯特大学取得国际商务的硕士学位。她曾任职德国麦肯锡顾问多年，专注于医药行业。她也曾在几家大型医药外企公司任职，如葛兰素史克，拜耳等。在过去几年中，曹女士曾在礼来制药担任新药业务拓展部的高级经理及集博公司的商务总监职位
Lingling Cao CEO & Founder
Lingling has more than a decade of experience in the healthcare industry, especially in deal-making. She founded Lingmed, which aims to support BD professionals to make better decisions with intelligence databases and EU-China cross-border deals. Prior to her venture at Lingmed, she was a senior BD manager for Eli Lilly in Shanghai and a consultant for McKinsey in Germany
王海盛 医学顾问
王博士在北京大学药物化学取得博士学位，并先后在密苏里大学圣路易斯分校及奥本大学从事过博士后研究工作。王海盛拥有10年以上的医药行业的从业经验，目前兼任美国药学科学家协会中国讨论组（AAPSCDG）主席；北京大学药学院兼职教授、专业硕士导师；中国医药生物技术协会(CMBA)生物医学信息技术分会委员；王博士是灵麦团队引进创新药品方面的专业顾
Dr. Hank Wang Medical advisor
Dr Wang holds a PhD degree on Medicinal Chemistry from Peking University, has a Postdoc experience in University of Missouri-Saint Louis, and worked as a Postdoc Fellow in Auburn University. Hank Wang has more than 10 years’ experience in pharmaceuticals industry. Hank has worked as Vice President and President of R&D at Beijing Haiyan Pharmaceutical Co., Ltd. - Yangtze River Pharmaceutical Group. Dr Wang advises Lingmed on innovative assets evaluation for China market
请点击文末“阅读原文” 马上注册吧或联系我们info@lingmed.net
灵麦医药是以下两家情报数据库在中国的独家合作伙伴：
Biotechgate/博谷 - 全球创新药和器械产品收购和引进数据库
EvaluatePharma/预估医药 - 全球医药研发、销售、市场预估等竞争情报数据库
或点击下方“阅读原文”马上注册吧